USPTO Rejects Life Tech's Thermal Cycler Patent in Initial Ruling; EPO Upholds European Counterpart | GenomeWeb

By Bernadette Toner

This story was originally posted on Nov. 19.

The US Patent and Trademark Office has rejected all 12 claims in a key US patent related to real-time PCR thermal cycler technology that is assigned to Life Technologies' Applied Biosystems subsidiary.

The European Patent Office, meantime, last week issued a decision to maintain the European counterpart of the patent in an "amended form."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.